Pauperization of Emerin from nuclear envelope during chromatin bridge resolution drives prostate cancer cell migration and invasiveness

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract Micronuclei (MN) can arise from many causes, including the breakage of aberrant cytokinetic chromatin bridge. The frequent observation of MN in tumors raises the specter that they might not merely be passive elements but could instead play active roles in tumor progression. Here, we propose a mechanism that the presence of micronuclei could induce specific phenotypic and functional changes to the cell and lead to increased cancer invasive potential. Through the integration of diverse imaging and molecular techniques in vitro, supported by clinical samples from D’Amico high-risk prostate cancer (PCa) patients, our study demonstrates that the resolution of chromosome bridges can result in the accumulation of EMD and the formation of EMD-rich MN. Such structure is negative for Lamin A/C, positive for Lamin-B receptor and Sec61β. It can act as a protein sink and result in EMD pauperization from the nuclear envelope. The phenotype of emerin mis-localization is associated with molecular signature that correlates to worse prognosis in PCa and is enriched in metastatic samples. Emerin mis-localization corresponds with migratory and invasive properties of tumor cells, especially in the context collagen-rich microenvironment. Our study demonstrates that the mis-localization of emerin to MN induces increased cell invasiveness, thereby exacerbating patient’s prognosis.
Full text 20,799 characters · extracted from preprint-html · click to expand
Pauperization of Emerin from nuclear envelope during chromatin bridge resolution drives prostate cancer cell migration and invasiveness | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Pauperization of Emerin from nuclear envelope during chromatin bridge resolution drives prostate cancer cell migration and invasiveness Paulina Nastaly, Marta Popęda, Kamil Kowalski, Tomasz Wenta, Galina Beznoussenko, and 14 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3533837/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 02 Sep, 2024 Read the published version in Experimental & Molecular Medicine → Version 1 posted You are reading this latest preprint version Abstract Micronuclei (MN) can arise from many causes, including the breakage of aberrant cytokinetic chromatin bridge. The frequent observation of MN in tumors raises the specter that they might not merely be passive elements but could instead play active roles in tumor progression. Here, we propose a mechanism that the presence of micronuclei could induce specific phenotypic and functional changes to the cell and lead to increased cancer invasive potential. Through the integration of diverse imaging and molecular techniques in vitro, supported by clinical samples from D’Amico high-risk prostate cancer (PCa) patients, our study demonstrates that the resolution of chromosome bridges can result in the accumulation of EMD and the formation of EMD-rich MN. Such structure is negative for Lamin A/C, positive for Lamin-B receptor and Sec61β. It can act as a protein sink and result in EMD pauperization from the nuclear envelope. The phenotype of emerin mis-localization is associated with molecular signature that correlates to worse prognosis in PCa and is enriched in metastatic samples. Emerin mis-localization corresponds with migratory and invasive properties of tumor cells, especially in the context collagen-rich microenvironment. Our study demonstrates that the mis-localization of emerin to MN induces increased cell invasiveness, thereby exacerbating patient’s prognosis. Biological sciences/Cell biology/Mechanisms of disease Biological sciences/Cancer/Urological cancer/Prostate cancer Biological sciences/Cell biology/Nuclear organization/Nuclear envelope Micronuclei chromatin bridge nuclear envelope emerin prostate cancer metastasis Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryMovie1.avi Supplementary Movie 1 SupplementaryMovie2.avi Supplementary Movie 2 SupplementaryMovie3.avi Supplementary Movie 3 SupplementaryMovie4.avi Supplementary Movie 4 SupplementaryMovie5.avi Supplementary Movie 5 SupplementaryMovie6.avi Supplementary Movie 6 PopedaetalSupplementaryInformationver191023.pdf Cite Share Download PDF Status: Published Journal Publication published 02 Sep, 2024 Read the published version in Experimental & Molecular Medicine → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3533837","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":245687106,"identity":"a84ee441-1123-4404-a413-b93d4ea8b542","order_by":0,"name":"Paulina Nastaly","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0003-4811-4915","institution":"Medical University of Gdansk","correspondingAuthor":true,"prefix":"","firstName":"Paulina","middleName":"","lastName":"Nastaly","suffix":""},{"id":245687107,"identity":"70eced59-2edd-47ba-822a-2524cfd4ec8b","order_by":1,"name":"Marta Popęda","email":"","orcid":"https://orcid.org/0000-0002-4596-4837","institution":"Medical University of Gdansk","correspondingAuthor":false,"prefix":"","firstName":"Marta","middleName":"","lastName":"Popęda","suffix":""},{"id":245687108,"identity":"34563bc2-c75d-481a-bca7-adba2610893e","order_by":2,"name":"Kamil Kowalski","email":"","orcid":"","institution":"Medical University of Gdansk","correspondingAuthor":false,"prefix":"","firstName":"Kamil","middleName":"","lastName":"Kowalski","suffix":""},{"id":245687109,"identity":"8e9a2633-bed7-405d-a7e8-832b226bccd5","order_by":3,"name":"Tomasz Wenta","email":"","orcid":"","institution":"Department of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Gdansk, Poland","correspondingAuthor":false,"prefix":"","firstName":"Tomasz","middleName":"","lastName":"Wenta","suffix":""},{"id":245687110,"identity":"ef0b82ca-f0a7-49d3-a65b-e6171178581f","order_by":4,"name":"Galina Beznoussenko","email":"","orcid":"https://orcid.org/0000-0002-1876-4098","institution":"IFOM - FIRC Institute of Molecular Oncology","correspondingAuthor":false,"prefix":"","firstName":"Galina","middleName":"","lastName":"Beznoussenko","suffix":""},{"id":245687111,"identity":"c13183fc-c043-47a6-8ebd-eaaa39f1e471","order_by":5,"name":"Michal Rychlowski","email":"","orcid":"","institution":"University of Gdansk","correspondingAuthor":false,"prefix":"","firstName":"Michal","middleName":"","lastName":"Rychlowski","suffix":""},{"id":245687112,"identity":"d1aaa767-678f-4a4b-ba43-add9ead9d029","order_by":6,"name":"Alexandre Mironov","email":"","orcid":"","institution":"","correspondingAuthor":false,"prefix":"","firstName":"Alexandre","middleName":"","lastName":"Mironov","suffix":""},{"id":245687113,"identity":"84ea9e8a-0f9c-4e36-a5f3-0f23d0022e1d","order_by":7,"name":"Zeno Lavagnino","email":"","orcid":"","institution":"IFOM ETS - The AIRC Institute of Molecular Oncology","correspondingAuthor":false,"prefix":"","firstName":"Zeno","middleName":"","lastName":"Lavagnino","suffix":""},{"id":245687114,"identity":"d4eef802-f3a0-43e0-8729-88e51a4025b5","order_by":8,"name":"Sara Barozzi","email":"","orcid":"","institution":"ifom","correspondingAuthor":false,"prefix":"","firstName":"Sara","middleName":"","lastName":"Barozzi","suffix":""},{"id":245687115,"identity":"67ea113b-4507-4926-aeec-2241cc10391e","order_by":9,"name":"Julia Richert","email":"","orcid":"","institution":"Medical University of Gdansk","correspondingAuthor":false,"prefix":"","firstName":"Julia","middleName":"","lastName":"Richert","suffix":""},{"id":245687116,"identity":"96cae20c-4ac9-4c73-ba5c-5d67334b7ea5","order_by":10,"name":"Rebecca Bertolio","email":"","orcid":"","institution":"International Centre for Genetic Engineering and Biotechnology","correspondingAuthor":false,"prefix":"","firstName":"Rebecca","middleName":"","lastName":"Bertolio","suffix":""},{"id":245687117,"identity":"504995db-c9ba-4dc4-91b9-8469d6484346","order_by":11,"name":"Jolanta Szade","email":"","orcid":"","institution":"Department of Pathomorphology, Medical University of Gdańsk","correspondingAuthor":false,"prefix":"","firstName":"Jolanta","middleName":"","lastName":"Szade","suffix":""},{"id":245687118,"identity":"b8f6efb2-a9a6-4a22-a30a-becd414a4c47","order_by":12,"name":"Kevin Miszewski","email":"","orcid":"","institution":"Department of Urology, Medical University of Gdańsk","correspondingAuthor":false,"prefix":"","firstName":"Kevin","middleName":"","lastName":"Miszewski","suffix":""},{"id":245687119,"identity":"79b57f55-46f3-4c4e-ad9f-1c50b52893c5","order_by":13,"name":"Marcin Matuszewski","email":"","orcid":"","institution":"Department of Urology, Medical University of Gdańsk","correspondingAuthor":false,"prefix":"","firstName":"Marcin","middleName":"","lastName":"Matuszewski","suffix":""},{"id":245687120,"identity":"fcce00b3-29fc-4d74-8e0b-abc434024ede","order_by":14,"name":"Anna Żaczek","email":"","orcid":"","institution":"Division of Translational Oncology, Medical University of Gdansk","correspondingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Żaczek","suffix":""},{"id":245687121,"identity":"26b83240-cdc6-488d-b29f-fc9d27aac139","order_by":15,"name":"Luca Braga","email":"","orcid":"https://orcid.org/0000-0002-9827-6755","institution":"British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine \u0026 Sciences, King's College London","correspondingAuthor":false,"prefix":"","firstName":"Luca","middleName":"","lastName":"Braga","suffix":""},{"id":245687122,"identity":"6daa5809-14af-4a7b-aff4-f36386f5275b","order_by":16,"name":"Giannino Del Sal","email":"","orcid":"","institution":"International Centre for Genetic Engineering and Biotechnology","correspondingAuthor":false,"prefix":"","firstName":"Giannino","middleName":"Del","lastName":"Sal","suffix":""},{"id":245687123,"identity":"4ccb14d2-aab7-4be0-abcb-9327f3cfe24d","order_by":17,"name":"Natalia Bednarz-Knoll","email":"","orcid":"","institution":"Division of Translational Oncology, Medical University of Gdansk","correspondingAuthor":false,"prefix":"","firstName":"Natalia","middleName":"","lastName":"Bednarz-Knoll","suffix":""},{"id":245687124,"identity":"12e1e962-2538-4f4c-80c3-896a09c42e0d","order_by":18,"name":"Paolo Maiuri","email":"","orcid":"https://orcid.org/0000-0001-5079-445X","institution":"Università degli Studi di Napoli Federico II","correspondingAuthor":false,"prefix":"","firstName":"Paolo","middleName":"","lastName":"Maiuri","suffix":""}],"badges":[],"createdAt":"2023-11-01 10:16:44","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3533837/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3533837/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s12276-024-01308-w","type":"published","date":"2024-09-02T04:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":63998536,"identity":"ee9ae7aa-9ccb-4fcd-a6fc-dc2361ecf22d","added_by":"auto","created_at":"2024-09-04 18:19:17","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2549563,"visible":true,"origin":"","legend":"Article File","description":"","filename":"Popedaetalmanuscriptver011123.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1_covered_6062cd65-4584-421e-bd35-1e6a4b6a7867.pdf"},{"id":54550407,"identity":"4af01827-a1e7-4a36-95cd-c225542299e1","added_by":"auto","created_at":"2024-04-12 07:25:29","extension":"avi","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":988094,"visible":true,"origin":"","legend":"Supplementary Movie 1","description":"","filename":"SupplementaryMovie1.avi","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1/57a7c582405a7fe5f0776712.avi"},{"id":54550389,"identity":"f5d9a419-564c-4ede-baa3-d912460ea904","added_by":"auto","created_at":"2024-04-12 07:25:25","extension":"avi","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":2956242,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Movie 2\u003c/p\u003e","description":"","filename":"SupplementaryMovie2.avi","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1/474c938b469264c0771fc16b.avi"},{"id":54550404,"identity":"df15f7be-03f4-4e0c-8193-8b483caf0669","added_by":"auto","created_at":"2024-04-12 07:25:28","extension":"avi","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":1168048,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Movie 3\u003c/p\u003e","description":"","filename":"SupplementaryMovie3.avi","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1/bb2f263fd2e7d021455830ce.avi"},{"id":54550909,"identity":"1e156b2a-d5ad-4b8a-ba8f-93bc18798806","added_by":"auto","created_at":"2024-04-12 07:33:25","extension":"avi","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":1743832,"visible":true,"origin":"","legend":"Supplementary Movie 4","description":"","filename":"SupplementaryMovie4.avi","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1/6626ed8a90ade6b9b37f6a90.avi"},{"id":54550405,"identity":"0c75302d-99d1-4bcf-b6d5-5c0002687dd8","added_by":"auto","created_at":"2024-04-12 07:25:28","extension":"avi","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":1008858,"visible":true,"origin":"","legend":"Supplementary Movie 5","description":"","filename":"SupplementaryMovie5.avi","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1/10553706104902dbf1bf0006.avi"},{"id":54550402,"identity":"235849dc-424d-40d9-9bcd-3a3779b15811","added_by":"auto","created_at":"2024-04-12 07:25:28","extension":"avi","order_by":6,"title":"","display":"","copyAsset":false,"role":"supplement","size":29862,"visible":true,"origin":"","legend":"Supplementary Movie 6","description":"","filename":"SupplementaryMovie6.avi","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1/a90b457ff9f5c5aade7c1c08.avi"},{"id":54550928,"identity":"b82246ba-c4e9-46dd-abd6-b86166b7abe3","added_by":"auto","created_at":"2024-04-12 07:33:28","extension":"pdf","order_by":7,"title":"","display":"","copyAsset":false,"role":"supplement","size":196235,"visible":true,"origin":"","legend":"","description":"","filename":"PopedaetalSupplementaryInformationver191023.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3533837/v1/de0bc48bf567d48c670a5212.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Pauperization of Emerin from nuclear envelope during chromatin bridge resolution drives prostate cancer cell migration and invasiveness","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"experimental-and-molecular-medicine","isNatureJournal":false,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"emm","sideBox":"Learn more about [Experimental \u0026 Molecular Medicine](http://www.nature.com/emm/)","snPcode":"12276","submissionUrl":"https://mts-emm.nature.com/cgi-bin/main.plex","title":"Experimental \u0026 Molecular Medicine","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Micronuclei, chromatin bridge, nuclear envelope, emerin, prostate cancer, metastasis","lastPublishedDoi":"10.21203/rs.3.rs-3533837/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3533837/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eMicronuclei (MN) can arise from many causes, including the breakage of aberrant cytokinetic chromatin bridge. The frequent observation of MN in tumors raises the specter that they might not merely be passive elements but could instead play active roles in tumor progression. Here, we propose a mechanism that the presence of micronuclei could induce specific phenotypic and functional changes to the cell and lead to increased cancer invasive potential. Through the integration of diverse imaging and molecular techniques in vitro, supported by clinical samples from D\u0026rsquo;Amico high-risk prostate cancer (PCa) patients, our study demonstrates that the resolution of chromosome bridges can result in the accumulation of EMD and the formation of EMD-rich MN. Such structure is negative for Lamin A/C, positive for Lamin-B receptor and Sec61β. It can act as a protein sink and result in EMD pauperization from the nuclear envelope. The phenotype of emerin mis-localization is associated with molecular signature that correlates to worse prognosis in PCa and is enriched in metastatic samples. Emerin mis-localization corresponds with migratory and invasive properties of tumor cells, especially in the context collagen-rich microenvironment. Our study demonstrates that the mis-localization of emerin to MN induces increased cell invasiveness, thereby exacerbating patient\u0026rsquo;s prognosis.\u003c/p\u003e","manuscriptTitle":"Pauperization of Emerin from nuclear envelope during chromatin bridge resolution drives prostate cancer cell migration and invasiveness","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-04-12 07:25:17","doi":"10.21203/rs.3.rs-3533837/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"experimental-and-molecular-medicine","isNatureJournal":false,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"emm","sideBox":"Learn more about [Experimental \u0026 Molecular Medicine](http://www.nature.com/emm/)","snPcode":"12276","submissionUrl":"https://mts-emm.nature.com/cgi-bin/main.plex","title":"Experimental \u0026 Molecular Medicine","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"6de5009b-cc7a-4282-9d21-2322e23d5e6c","owner":[],"postedDate":"April 12th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":25944582,"name":"Biological sciences/Cell biology/Mechanisms of disease"},{"id":25944583,"name":"Biological sciences/Cancer/Urological cancer/Prostate cancer"},{"id":25944584,"name":"Biological sciences/Cell biology/Nuclear organization/Nuclear envelope"}],"tags":[],"updatedAt":"2024-09-04T17:39:52+00:00","versionOfRecord":{"articleIdentity":"rs-3533837","link":"https://doi.org/10.1038/s12276-024-01308-w","journal":{"identity":"experimental-and-molecular-medicine","isVorOnly":false,"title":"Experimental \u0026 Molecular Medicine"},"publishedOn":"2024-09-02 04:00:00","publishedOnDateReadable":"September 2nd, 2024"},"versionCreatedAt":"2024-04-12 07:25:17","video":"","vorDoi":"10.1038/s12276-024-01308-w","vorDoiUrl":"https://doi.org/10.1038/s12276-024-01308-w","workflowStages":[]},"version":"v1","identity":"rs-3533837","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3533837","identity":"rs-3533837","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00